PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 17 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,026,000 | – | 20,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |